ranitidine has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freeman, A; Gertz, BJ; Holland, SD; Kline, WF; Lasseter, KC; Matuszewski, BK; Mucklow, JC; Porras, AG; Quan, H | 1 |
| Adachi, Y; Iso, Y; Kitano, S; Matsumata, T; Shiota, E; Yoh, R | 1 |
1 trial(s) available for ranitidine and Osteoporosis
| Article | Year |
|---|---|
Studies of the oral bioavailability of alendronate.
Topics: Achlorhydria; Administration, Oral; Adult; Aged; Alendronate; Analysis of Variance; Beverages; Biological Availability; Calcium; Cross-Over Studies; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Food; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Ranitidine | 1995 |
1 other study(ies) available for ranitidine and Osteoporosis
| Article | Year |
|---|---|
Bone mineral density in patients taking H2-receptor antagonist.
Topics: Adult; Aged; Bone Density; Case-Control Studies; Cimetidine; Duodenal Ulcer; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Multivariate Analysis; Osteoporosis; Ranitidine; Stomach Ulcer; Time Factors | 1998 |